GlaxoSmithKline CR`s Net Debt/EBITDA reached -2.15 in 2017. This is 61.7 % less than in the previous year.
Buy Net Debt/EBITDA data for GlaxoSmithKline Czech Republic.
$19.99Buy all data for GlaxoSmithKline Czech Republic.
Buy annual subscriptions for all our products.
| Company | Unit | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| Amgen Czech Republic | ... | ... | ... | ... | ... | 0 | 0 | -0.005 | 0.709 | 1.53 | |||||||||
| Bayer Czech Republic | ... | ... | ... | -0.298 | -0.098 | 0.140 | 0.150 | 0.890 | |||||||||||
| GlaxoSmithKline Czech Republic | ... | ... | ... | 0.438 | 1.02 | 1.69 | -0.001 | -3.71 | |||||||||||
| Merck Czech Republic | ... | ... | 1.87 | 1.39 | 2.80 | 0.353 | -0.026 | ||||||||||||
| Novartis Czech Republic | 3.22 | 0.696 | -0.064 | 0.826 | -0.015 | ||||||||||||||
| Pfizer Czech Republic | ... | ... | 2.16 | -1.32 | -0.141 | -1.65 | -0.037 | ||||||||||||
| Roche Czech Republic | ... | ... | ... | -0.002 | 0.737 | 0.867 | 2.04 | 3.15 | ... | ||||||||||
| Sanofi-Aventis Czech Republic | ... | ... | ... | ... | 12.8 | 16.5 | 8.87 | 27.7 | 4.27 | ||||||||||
| Servier Czech Republic | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -1.54 | -2.09 | -1.74 | -0.839 | |||
| Walmark | ... | ... | ... | 0.471 | 4.81 | 4.37 | 2.26 | -5.37 |
Helgi Library 
